Atlas Trials

Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions

Clinical trial NCT05290948 · UNKNOWN

Trial details

NCT number
NCT05290948
Sponsor
Shahid Beheshti University of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Macular Edema
Start date
2022-03-12
Primary completion
2022-07-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.